This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Meena PhD
SVP, Translational DMPK and Clinical Pharmacology at Stoke Therapeutics
Speaker

Agenda Sessions

  • Utilization of Oligonucleotides’ Half-Life to Optimize Dosing Regimen for Desirable Efficacy & Reduced CNS Toxicity

    , 2:00pm
    View Session

At this event

Prev
Next
Gerard Platenburg, PhD
Chief Scientific Officer
ProQR Therapeutics

See Meena at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now